Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
FibroGen
Pharma
BeiGene, BMS, AZ-FibroGen and more—Fierce Pharma Asia
BeiGene added 1,400 staffers in the past 12 months. BMS opened a new innovation hub in India. AZ held onto Evrenzo in China but ditched U.S. rights.
Angus Liu
Mar 1, 2024 8:55am
AstraZeneca finally drops roxadustat US rights
Feb 27, 2024 11:28am
GSK scraps plan to launch oral anemia drug beyond US, Japan
Jul 26, 2023 10:21am
FibroGen CEO Enrique Conterno hits the exit after 3-year stint
Jul 25, 2023 2:02pm
Akebia finds new partner for oral anemia drug in Europe
May 25, 2023 10:56am
Takeda, AstraZeneca, Astellas and more—Fierce Pharma Asia
May 19, 2023 9:25am